Emerging targets in gastric and pancreatic cancer: Focus on claudin 18.2
Cancer Letters · 2025-02 · 611 · 217362
DOI: 10.1016/j.canlet.2024.217362 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-02. Verfasst von Alireza Tojjari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, 15213, USA. Electronic add…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Pancreatic Neoplasms, Claudins. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recently, the molecular landscape of gastric and pancreatic cancers has advanced with Claudin 18.2 (CLDN18.2) emerging as a promising therapeutic target. Claudin 18.2, a tight junction protein, is selectively expressed in cancer cells and minimally in normal tissues, making it an attractive candidate for targeted therapy. Therapies like monoclonal antibodies (e.g., zolbetuximab), bispecific antibodies, and antibody-drug conjugates have shown significant potential in improving clinical outcomes. Early-phase clinical trials demonstrate robust antitumor activity, particularly in combination with chemotherapy and immunotherapy regimens. However, challenges such as patient selection, resistance mechanisms, and toxicity management remain critical. This review highlights the therapeutic landscape, clinical advancements, and future directions of targeting Claudin 18.2 in gastric and pancreatic cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, 15213, USA. Electronic address: alirezatojjari@gmail.com.
- Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, 15213, USA. Electronic address: yalamiidr@gmail.com.
- Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, 15213, USA; UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA. Electronic address: saeeda3@…
Zitieren
APA
Tojjari, A., Idrissi, Y. A., & Saeed, A. (2025). Emerging targets in gastric and pancreatic cancer: Focus on claudin 18.2. Cancer Letters, 611, 217362. https://doi.org/10.1016/j.canlet.2024.217362
Vancouver
Tojjari A, Idrissi YA, Saeed A. Emerging targets in gastric and pancreatic cancer: Focus on claudin 18.2. Cancer Letters. 2025;611:217362. doi:10.1016/j.canlet.2024.217362
BibTeX
@article{Tojjari2025,
author = {Tojjari, Alireza and Idrissi, Yassine Alami and Saeed, Anwaar},
title = {Emerging targets in gastric and pancreatic cancer: Focus on claudin 18.2},
journal = {Cancer Letters},
year = {2025},
volume = {611},
pages = {217362},
doi = {10.1016/j.canlet.2024.217362}
}
EUVIMED